Ce site contient du contenu archivé

Visitez notre nouveau site web: https://neuroquebec.com/

PDK4 Inhibition Ameliorates Melatonin Therapy by Modulating Cerebral Metabolism and Remyelination in an EAE Demyelinating Mouse Model of Multiple Sclerosis.